Report to the NHS Central Research & Development Committee
Annex 6 - Letter Inviting Evidence










28 July 1993

Dear Sir/Madam

NHS PRIORITIES IN RESEARCH AND DEVELOPMENT (R&D) RELATING TO CANCER

I am writing to seek your input into identifying NHS priorities for R&D in relation to cancer.

As you may know, a new R&D strategy for the NHS was launched in 1991. The Central Research and Development Committee (CRDC) for the NHS is advising on R&D priorities and has formed a number of Expert Advisory Groups to support this work. An Advisory Group on R&D priorities relating to cancer is being established under the chairmanship of Professor Peter Selby, University of Leeds.

A key operating feature of the Advisory Groups is widespread consultation with the NHS and interested outside bodies. We are seeking your opinion on what you consider are the most important problems and NHS needs in all fields of cancer which could usefully be addressed by research and development. You may also wish to identify opportunities of potential great value to the NHS in cancer.

Please note that what is sought are not definite research proposals. It would be helpful if your contribution could be as concise as possible and, preferably, limited to about three priority areas. Please state for each:
  1. The question
  2. A statement showing why the topic is important
  3. References.

Evidence received from the NHS, professional bodies, consumer groups, the research community and others will be used by the Advisory Group to formulate specific questions that can be answered by R&D. The consultation list is attached for your information; it would be helpful to know of any further organisations you think should be contacted.

The Advisory Group will start work in the autumn and will be reporting to the CRDC in spring 1994. In order for your submission to be used to the maximum effect, we would ask for responses to be sent to Mr K Preece, Research and Development Directorate, Room GW41, Quarry House, Quarry Hill, Leeds LS2 7UE by 24 September, although earlier responses would be helpful. We are expecting a substantial number of responses and it may not be possible to acknowledge all material sent to us, for which I make advance apology. However, all those responding will receive a copy of the final report in due course.

Thank you in advance for your co-operation; the input of those working, managing and using the services is essential in identifying R&D priorities which will be of greatest relevance and use to the NHS.

Yours sincerely

Dr John Toy PhD FRCP
Senior Medical Officer
Research and Development Division

Next Page (Annex 7 - Rating Criteria and Scoring Guidelines)
CRDC Report: Contents Page
 
  © Crown copyright, Department of Health. All rights reserved.
Last updated 22 November 2004
Page maintained by Helen Bailey
 This page looks best when viewed with either MS Internet Explorer or Netscape Navigator.